UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trials in 2025, this ther…
Related Posts
CoinSwitch Sues WazirX in Attempt to Recover $9.65 Million of Its Own Funds
In a detailed post published on X, CoinSwitch disclosed that two percent of its total funds — worth Rs. 810 crore (roughly Rs. 9.65 million) […]
Thailand Approves USDT and USDC for Crypto Trading and Banking Settlements
- staff
- March 11, 2025
- 0
Thailand’s Securities and Exchange Commission (SEC) has added USDT and USDC to its approved token list. The Bank of Thailand will also explore their use […]
X Said to Be Unlikely to Fall Under Landmark EU Tech Rules
X, the microblogging platform owned by Elon Musk, is said to be unlikely to be affected by the EU’s significant tech regulations — the Digital […]